Monday, 07 November 2022 13:16

FDA wants to develop a comprehensive strategy to phase out animal testing Featured

According to a Nature article, officials at the U.S. Food and Drug Administration (FDA) want to allocat a portion of their 2023 budget request to develop a "comprehensive strategy" for alternative methods of testing (NAMs).

The goal is to use NAMs to make discoveries that are more relevant to humans, streamline product development and reduce costs, the report says.

The strategy is to be funded with $5 million, a portion of the agency's 2023 budget request.  

More information: